219 related articles for article (PubMed ID: 31179511)
21. Autoimmune Cerebellar Ataxia: Etiology and Clinical Characteristics of a Case Series from China.
Liu M; Ren H; Zhu Y; Fan S; Bai L; Wang J; Cui L; Guan H
Cerebellum; 2023 Jun; 22(3):379-385. PubMed ID: 35618871
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies in childhood post-varicella acute cerebellar ataxia.
Adams C; Diadori P; Schoenroth L; Fritzler M
Can J Neurol Sci; 2000 Nov; 27(4):316-20. PubMed ID: 11097523
[TBL] [Abstract][Full Text] [Related]
23. Neuronal antibodies in nonparaneoplastic autoimmune cerebellar ataxias.
Saiz A; Graus F
Curr Opin Neurol; 2024 Jun; 37(3):322-328. PubMed ID: 38483149
[TBL] [Abstract][Full Text] [Related]
24. Caspr2 antibodies in limbic encephalitis with cerebellar ataxia, dyskinesias and myoclonus.
Balint B; Regula JU; Jarius S; Wildemann B
J Neurol Sci; 2013 Apr; 327(1-2):73-4. PubMed ID: 23465509
[TBL] [Abstract][Full Text] [Related]
25. Anti-contactin-associated protein-like 2 antibody-associated cerebellar ataxia: A case report and literature review.
Wang J; Qiu Z; Li D; Dong H; Hao J; Liu Z
J Neuroimmunol; 2021 Apr; 353():577515. PubMed ID: 33640718
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune Cerebellar Ataxia Associated with Anti-Glutamate Receptor δ2 Antibodies: a Rare but Treatable Entity.
Khatib L; Do LD; Benaiteau M; Villagrán-García M; Scharf M; Meyer P; Haidar LA; Demeret S; Honnorat J
Cerebellum; 2024 Feb; 23(1):260-266. PubMed ID: 36696031
[TBL] [Abstract][Full Text] [Related]
27. Nonparaneoplastic autoimmune cerebellar ataxias.
Joubert B; Honnorat J
Curr Opin Neurol; 2019 Jun; 32(3):484-492. PubMed ID: 30694927
[TBL] [Abstract][Full Text] [Related]
28. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia.
Nanri K; Okita M; Takeguchi M; Taguchi T; Ishiko T; Saito H; Otsuka T; Mitoma H; Koizumi K
Intern Med; 2009; 48(10):783-90. PubMed ID: 19443972
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of oral corticosteroids therapy in anti-glutamic acid decarboxylase antibodies cerebellar ataxia.
di Biase L; Assenza G; Iorio R; Melgari JM; Salomone G; Marano M; Muda AO; Di Lazzaro V
Parkinsonism Relat Disord; 2016 Sep; 30():78-80. PubMed ID: 27236207
[No Abstract] [Full Text] [Related]
30. Neurochondrin neurological autoimmunity.
Shelly S; Kryzer TJ; Komorowski L; Miske R; Anderson MD; Flanagan EP; Hinson SR; Lennon VA; Pittock SJ; McKeon A
Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):. PubMed ID: 31511329
[TBL] [Abstract][Full Text] [Related]
31. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
32. Low-titer anti-GAD-antibody-positive cerebellar ataxia.
Nanri K; Niwa H; Mitoma H; Takei A; Ikeda J; Harada T; Okita M; Takeguchi M; Taguchi T; Mizusawa H
Cerebellum; 2013 Apr; 12(2):171-5. PubMed ID: 22923147
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia.
Jarius S; Scharf M; Begemann N; Stöcker W; Probst C; Serysheva II; Nagel S; Graus F; Psimaras D; Wildemann B; Komorowski L
J Neuroinflammation; 2014 Dec; 11():206. PubMed ID: 25498830
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG.
Honorat JA; Lopez-Chiriboga AS; Kryzer TJ; Komorowski L; Scharf M; Hinson SR; Lennon VA; Pittock SJ; Klein CJ; McKeon A
Neurology; 2019 Sep; 93(10):e954-e963. PubMed ID: 31371564
[TBL] [Abstract][Full Text] [Related]
35. Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia.
Damato V; Papi C; Spagni G; Evoli A; Silvestri G; Masi G; Sabatelli E; Campetella L; McKeon A; Andreetta F; Riso V; Monte G; Luigetti M; Primiano G; Calabresi P; Iorio R
Eur J Neurol; 2022 Feb; 29(2):564-572. PubMed ID: 34710286
[TBL] [Abstract][Full Text] [Related]
36. [A case of human immunodeficiency virus infection with cerebellar ataxia that suggested by an association with autoimmunity].
Nagao S; Kondo T; Nakamura T; Nakagawa T; Matsumoto S
Rinsho Shinkeigaku; 2016 Apr; 56(4):255-9. PubMed ID: 27010096
[TBL] [Abstract][Full Text] [Related]
37. Clinical Features and Neuroimaging Findings of Neuropil Antibody-Positive Idiopathic Sporadic Ataxia of Unknown Etiology.
Takekoshi A; Kimura A; Yoshikura N; Yamakawa I; Urushitani M; Nakamura K; Yoshida K; Shimohata T
Cerebellum; 2023 Oct; 22(5):915-924. PubMed ID: 36057079
[TBL] [Abstract][Full Text] [Related]
38. High Titer of Circulating Antiglutamic Acid Decarboxylase Antibodies in a Patient with Cerebellar Ataxia and Type 1 Diabetes.
Kataria R; Fernandes S; Lebastchi J; Bravo CA; Sena KN
Conn Med; 2017 Mar; 81(3):161-164. PubMed ID: 29772159
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
[TBL] [Abstract][Full Text] [Related]
40. Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration.
de Graaff E; Maat P; Hulsenboom E; van den Berg R; van den Bent M; Demmers J; Lugtenburg PJ; Hoogenraad CC; Sillevis Smitt P
Ann Neurol; 2012 Jun; 71(6):815-24. PubMed ID: 22447725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
